Healthcare & Life Sciences

VisEn Medical

United States
acquiredacquired
acquired
Stage

About

VisEn Medical developed in vivo molecular imaging systems and fluorescent imaging reagents for cancer, cardiovascular, skeletal, and pulmonary applications before being acquired by PerkinElmer in 2010.

Explore VisEn Medical's full profile on Brouky

Funding rounds, investor list, and risk signals — unlock with a subscription.